ME 23andMe
- 0.340
- +0.010+3.00%
- 0.339
- -0.001-0.32%
23andMe News
What Happened to 23andMe? | CNN Business
Wolf Popper LLP Is Investigating Whether the Offer to Acquire 23andMe Holding Co. By Its Controlling Shareholder Is Fair to the Minority Shareholders
How 23andMe Went From Market Darling to Losing Its Entire Board -- Barrons.com
Express News | 23Andme Holding Co.: Pursuant to Nasdaq Letter, Co Has Until Oct 3 to Submit Plan to Regain Compliance
Express News | 23Andme Holding Co. -Got Deficiency Letter From Nasdaq, Notifying That Co Not in Compliance With Nasdaq Listing Rule 5605
Every Single Member of the Board Just Resigned From DNA Tester 23andMe
Tupperware, UAW-Stellantis, 23andme: 3 Stories In Focus
Sector Update: Health Care Stocks Steady Premarket Wednesday
Mass Resignation at 23andMe Amid Strategic Disagreements
23andMe Shares Fall After Independent Directors Resign Amid Spat Over Buyout Bid
General Mills, Steelcase And 3 Stocks To Watch Heading Into Wednesday
23andMe CEO Anne Wojcicki 'Surprised and Disappointed' by Board Resignations: Read the Memo
Stocks to Watch: Intuitive Machines, 23andMe, Cibus
Express News | 23Andme Independent Directors, in Letter to CEO: Yet to Receive Fully Financed, Fully Diligenced, Actionable Proposal
Independent Directors of 23andMe Resign From Board
Express News | Independent Directors of 23Andme Resign From Board
Press Release: Independent Directors of 23andMe Resign From Board
Citi Maintains 23andMe(ME.US) With Hold Rating, Cuts Target Price to $0.42
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH) and 23andMe Holding (ME)
Hold Rating on 23andMe Amid Clinical and Acquisition Uncertainties
Analysis
Price Target
No Data
No Data